BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37883057)

  • 1. 68 Ga-FAPI-04 Detected Hepatic Arteriovenous Malformation in a Patient With IgA Nephropathy.
    Zhang Z; Ni X; Guo S; Zuo C; Cheng C
    Clin Nucl Med; 2023 Dec; 48(12):1096-1098. PubMed ID: 37883057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-Head Comparison of [
    Ballal S; Yadav MP; Roesch F; Raju S; Satapathy S; Sheokand P; Moon ES; Martin M; Awarwal S; Tripathi M; Bal C
    Thyroid; 2023 Aug; 33(8):974-982. PubMed ID: 37171126
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-DOTA-FAPI-04 PET/CT in Neuroendocrine Carcinoma of the Liver With Elevated AFP Level: Comparison With 18F-FDG PET/CT.
    Ergül N; Yılmaz B; Cin M; Çermik TF
    Clin Nucl Med; 2022 Jan; 47(1):e29-e31. PubMed ID: 34284483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68 Ga-DOTA-FAPI-04 PET/CT Imaging of Tracheal Mucoepidermoid Carcinoma.
    Peng D; Chen Q; Cao J; Huang Y; Chen Y
    Clin Nucl Med; 2022 Oct; 47(10):872-873. PubMed ID: 35619193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
    Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
    J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of
    Elboga U; Sahin E; Kus T; Cayirli YB; Aktas G; Okuyan M; Cinkir HY; Teker F; Sever ON; Aytekin A; Yılmaz L; Aytekin A; Cimen U; Mumcu V; Kilbas B; Eryilmaz K; Cakici D; Celen YZ
    Mol Imaging Biol; 2022 Oct; 24(5):789-797. PubMed ID: 35411447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Solitary Tuberculosis in the Hepatic Round Ligament Detected by 68Ga-FAPI PET/CT.
    Deng Y; Wu J; Xu C; Zhang W
    Clin Nucl Med; 2022 May; 47(5):e414-e416. PubMed ID: 35293356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68 Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of Cardiac Angiosarcoma.
    Xu T; Ding H; Ban H; Zhu Y; Chen Y
    Clin Nucl Med; 2022 Sep; 47(9):834-835. PubMed ID: 35426871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18 F-FDG and 68 Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor.
    Zhang Z; Yu Y; Zhang L; Cheng C; Zuo C
    Clin Nucl Med; 2022 Oct; 47(10):897-899. PubMed ID: 35485860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of PET imaging of activated fibroblasts and
    Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Activation Protein-Targeted PET/CT with
    Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
    J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting PET tracer [
    Wang R; Jakobsson V; Wang J; Zhao T; Peng X; Li B; Xue J; Liang N; Zhu Z; Chen X; Zhang J
    Theranostics; 2023; 13(9):2979-2992. PubMed ID: 37284441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.